-
Theo Wargo/Getty ImagesNPR critics remember some of their favorite Dolly performances — including a duet with Kermit the Frog and the twinkle in Dolly's eye singing with Linda Ronstadt and Emmylou Harris. -
Claire Harbage/NPRA big glass of moo juice — no, make that several glasses a day — is common in Rwanda. Is that too much of a good thing?
-
At least 1,500 people are missing, many of them foreign tourists, after deadly floods hit the Nepal-Tibet border, sweeping away entire villages. -
With the war in Iran driving up fuel prices, diesel is now nearly $5.60 a gallon, affecting school districts at the start of the year. -
Ossoff should be among the most vulnerable Senate incumbents this year. Instead, the Georgia Democrat has opened a steady lead in polls and is increasingly seen as a potential 2028 contender. -
Nondisclosure agreements covered up negotiations between a tech company and several local and state officials, surprising local residents. It's a tactic used around the country in data center deals.
Kevin Dietsch
/
Getty Images
A lawsuit seeks to block President Trump's name from going back on the center. The center's board warns that if renovation plans don't go forward, it may be demolished.
Daniel Mihailescu
/
AFP via Getty Images
-
2026 has already brought a wave of setbacks for social media giants as pressure grows on Big Tech from regulators and lawmakers around the world. -
U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor growth in the vast majority of cases. -
The official in charge of President Trump's ceasefire plan for Gaza criticized Israel for its attacks on the Palestinian territory and warned that the alternative to the U.S. proposal is the next war. -
The Japanese artist has died at age 97. Kusama's polka dotted pumpkins, "Infinity Rooms," and other repetitive and dreamlike artworks have been shown in museums and galleries worldwide. -
The Bridge program, which began July 1, makes some Medicare beneficiaries eligible for obesity drugs for $50 a month. CVS and Walgreens say they've each already filled 100,000 such prescriptions.
